Aytu BioPharma, Inc. (AYTU) stock declined over -0.30% intraday to trade at $0.67 a share on NASDAQ. The stock opened with a gain of 1.52% at $0.63 and touched an intraday high of $0.74, falling -0.00% against the last close of $0.67. The stock went to a low of $0.621 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue81.99 Million
5Y Sales Change91.30%
Fiscal Year Ends2021-06-29
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
Aytu BioPharma, Inc. (NASDAQ: AYTU) stock price is $0.67 as of the last check on Tuesday, July 5. During the trading session, AYTU stock reached the peak price of $0.74 while $0.621 was the lowest point it dropped to.
The NASDAQ listed AYTU is part of Pharmaceuticals industry that operates in the broader Health Care sector. Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.
Mr. Joshua R. Disbrow
Chairman & CEO
Mr. Mark K. Oki CPA
Chief Financial Officer
Mr. Jarrett T. Disbrow Ph.D.
Exec. VP of Corp. Operations
Mr. Greg Pyszczymuka
Chief Commercial Officer
AYTU stock traded closed the last session at $0.668, which is $0.00 or -0.30% lower than its previous close of $0.67. AYTU's current trading price is 48.44% lower than its 52-week high of $5.14 where as its distance from 52-week low of 0.45% is -87.00%.
Number of AYTU employees currently stands at -. AYTU operates from 373 Inverness Parkway, Suite 206, Englewood, CO 80112, United States.
Official Webiste of $AYTU is: https://aytubio.com
AYTU stock volume for the day was 1,296,417 shares while in the previous session number of AYTU shares traded was 1,258,427 . The average number of AYTU shares traded daily for last 3 months was 1.19 Million.
The percentage change in AYTU stock occurred in the recent session was -0.30% while the dollar amount for the price change in AYTU stock was $0.00.
In the recent session, the day high for AYTU stock was $0.74 while the low for AYTU stock touched on the day was $0.621.
The market value of AYTU currently stands at 26.52 Million with its latest stock price at $0.67 and 29.69 Million of its shares outstanding.